Bioorganic and Medicinal Chemistry Letters p. 907 - 912 (1997)
Update date:2022-08-04
Topics:
Astles, Peter C.
Brown, Thomas J.
Cox, Paul
Halley, Frank
Lockey, Peter M.
McCarthy, Clive
McLay, Iain M.
Majid, Tahir N.
Morley, Andrew D.
Porter, Barry
Ratcliffe, Andrew J.
Walsh, Roger J.A.
A series of phenylguanidines which bind to the C5a receptor has been developed. The lead compound 1 (IC50 = 30 μM), discovered through random screening, has been modified to provide 32 (RPR121154) with submicromolar activity. This compound was
View MoreNanjing Chemzam Pharmtech Co., Ltd.
Contact:+86-25-86462165,+86-13915979898
Address:C5-1，6 Maiyue Road，Maigaoqiao，Nanjing，Jiangsu，China
Contact:+86 512 6287 2180
Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Contact:+86-531-58668191 58668193 58668196 58661173
Address:No 55,Beixiaoxinzhuang West Street,Jinan City, Shandong Province
Contact:+86-371-67759225
Address:No.32, Jinsuo Road, High-tech Zone
Shanghai Dianyang Industry Co.,ltd
Contact:+86 21 6492 4669
Address:Chejing RD, Songjiang District, Shanghai, China
Doi:10.3184/174751912X13383107316656
(2012)Doi:10.1016/j.ejmech.2013.05.035
(2013)Doi:10.1002/ejic.201201427
(2013)Doi:10.1039/c39920001247
(1992)Doi:10.1055/s-0032-1316899
(2013)Doi:10.1021/ja972099o
(1997)
